Assessment of ventricular size and function in congenitally corrected transposition of the great arteries*

https://doi.org/10.1016/S0002-9149(83)80043-5Get rights and content

Twenty-four quantitative cineangiographic studies were performed in 19 patients with congenitally corrected transposition of the great arteries to assess right and left ventricular size and function. Ages ranged from 7 days to 44 years and associated lesions included ventricular septal defect (13 of 19), pulmonary stenosis (9 of 19), and systemic (tricuspid) valvular insufficiency (7 of 19). Systemic (anatomically right) ventricular end-diastolic volume was within normal limits in most patients and averaged 119% of predicted normal. Pulmonary (anatomically left) ventricular end-diastolic volume also was normal in most patients, averaged 112% of predicted, and was not different from systemic (right) ventricular end-diastolic volume. Systemic ventricular ejection fraction (RVEF) averaged 0.61 ± 0.02 and was not different from pulmonary ventricular ejection fraction (LVEF) (0.65 ± 0.02), but important differences were apparent when age was considered. With exclusion of 2 patients with hypoplastic systemic ventricles and 2 studies performed <6 months after open heart surgery, all 12 patients aged <10 years had a normal RVEF, whereas 2 of 5 patients aged >17 years had a definitely low RVEF and 1 of 5 had a value at the lower limit of normal. In children, systemic and pulmonary ventricular pump function is usually normal in congenitally corrected transposition of the great arteries and any deviation from normal should suggest ventricular hypoplasia or an increase in afterload. After childhood, systemic ventricular dysfunction is more common and may reflect the inability of the anatomic right ventricle to function as the systemic pumping chamber over a normal lifetime in most patients with congenitally corrected transposition of the great arteries.

References (24)

  • GrahamTP et al.

    Abnormalities of right ventricular function following Mustard operation for transposition of the great arteries

    Circulation

    (1975)
  • HaglerDJ et al.

    Right and left ventricular function after the Mustard procedure and transposition of the great arteries

    Am J Cardiol

    (1979)
  • Cited by (102)

    • Congenitally corrected transposition of the great arteries

      2018, Diagnosis and Management of Adult Congenital Heart Disease: Third Edition
    • Congenitally Corrected Transposition of the Great Arteries

      2017, Diagnosis and Management of Adult Congenital Heart Disease
    • Anatomic repair for corrected transposition with left ventricular outflow tract obstruction

      2013, Annals of Thoracic Surgery
      Citation Excerpt :

      From the patients’ medical records obtained from our outpatient clinic, including the echocardiography and catheter examination reports, the following variables were evaluated: (1) Survival rate and risk analysis by the Kaplan-Meyer method and Cox proposal hazard model; (2) Reoperation-free rate for the postoperative systemic ventricular outflow tract, right ventricular outflow tract, and pacemaker implantation for developed arrhythmia by the Kaplan-Meyer method; (3) postoperative intervention rate for caval obstruction and risk analysis by the Kaplan-Meyer method and log-rank test; (4) analysis of correlations between preoperative right ventricular volume and postoperative cardiac index ;and right ventricular end-diastolic pressure measured 1 year after the operation; and (5) New York Heart Association (NYHA) functional classification, current medication status, echocardiography findings, and biomarkers for heart failure as late clinical conditions. Right ventricular end diastolic volume was calculated using biplane right ventriculography findings [16, 17]. The VSD size was measured by both preoperative echocardiography and intraoperative direct inspection.

    View all citing articles on Scopus
    *

    This study was supported in part by Grant 1R01 HL-21985-02 RAD of the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.

    View full text